Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial
Despite lithium's being the most effective drug for bipolar disorder and in clinical use for decades, we still know very little about its early effects relevant to its mode of action.The Oxford Lithium Trial is a double-blind, randomised, placebo-controlled study of 6-week lithium treatment in...
Автори: | Saunders, K, Cipriani, A, Rendell, J, Attenburrow, M, Nelissen, N, Bilderbeck, A, Vasudevan, S, Churchill, G, Goodwin, G, Nobre, A, Harmer, C, Harrison, P, Geddes, J |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
BioMed Central
2016
|
Схожі ресурси
Схожі ресурси
-
Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomized controlled trial
за авторством: Saunders, K, та інші
Опубліковано: (2016) -
Older patients are eligible for trial of lithium and valproate.
за авторством: Rendell, J, та інші
Опубліковано: (2003) -
New trial should clarify lithium use in bipolar disorder.
за авторством: Geddes, J, та інші
Опубліковано: (2002) -
Lith6
за авторством: Malcolm A. Lyons, та інші
Опубліковано: (2003-09-01) -
The Oxford study of calcium channel antagonism, cognition, mood instability and sleep (OxCaMS): Study protocol for a randomised controlled, experimental medicine study
за авторством: Atkinson, L, та інші
Опубліковано: (2019)